ARTICLE | Company News
Adimab, Sanofi deal
February 16, 2015 8:00 AM UTC
Adimab and Sanofi partnered to develop and commercialize human antibodies or bispecific molecules against multiple undisclosed targets. Adimab will generate the molecules using its antibody discovery ...